Marijuana, the Endocannabinoid System and the Female Reproductive System

di Brents, Lisa K.
Pubblicato in Yale J Biol Med (2016)

The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products

di Brents, Lisa K., Prather, Paul L.
Pubblicazione 2013

Automated Quantification of Opioid Withdrawal in Neonatal Rat Pups Using Ethovision® XT Software

di Kulbeth, Hanna J., Fukuda, Saki, Brents, Lisa K.
Pubblicato in Neurotoxicol Teratol (2021)

Personality variables modify the relationship between childhood maltreatment history and poor functional outcomes

di Brents, Lisa K., James, G. Andrew, Cisler, Joshua M., Kilts, Clinton D.
Pubblicato in Psychiatry Res (2018)

Unifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs

di Safe, Stephen H., Prather, Paul L., Brents, Lisa K., Chadalapaka, Gayathri, Jutooru, Indira
Pubblicazione 2012

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors

di Rajasekaran, Maheswari, Brents, Lisa K., Franks, Lirit N., Moran, Jeffery H., Prather, Paul L.
Pubblicazione 2013

The role of childhood maltreatment in the altered trait and global expression of personality in cocaine addiction

di Brents, Lisa K, Tripathi, Shanti Prakash, Young, Jonathan, James, G Andrew, Kilts, Clinton D
Pubblicato in J Psychiatr Res (2015)

Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy

di Brents, Lisa K., Zimmerman, Sarah M., Saffell, Amanda R., Prather, Paul L., Fantegrossi, William E.
Pubblicazione 2013

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

di Brents, Lisa K., Reichard, Emily E., Zimmerman, Sarah M., Moran, Jeffery H., Fantegrossi, William E., Prather, Paul L.
Pubblicazione 2011

Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors

di Madadi, Nikhil Reddy, Penthala, Narsimha Reddy, Brents, Lisa K., Ford, Benjamin M., Prather, Paul L., Crooks, Peter A
Pubblicazione 2013

AM-251 and Rimonabant Act as Direct Antagonists at Mu-Opioid Receptors: Implications for Opioid/Cannabinoid Interaction Studies

di Seely, Kathryn A., Brents, Lisa K., Franks, Lirit N., Rajasekaran, Maheswari, Zimmerman, Sarah M., Fantegrossi, William E., Prather, Paul L.
Pubblicazione 2012

A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors

di Seely, Kathryn A., Brents, Lisa K., Radominska-Pandya, Anna, Endres, Gregory W., Keyes, Gregory S., Moran, Jeffery H., Prather, Paul L.
Pubblicazione 2012

Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer

di Liu, Xinyi, Jutooru, Indira, Lei, Ping, Kim, KyoungHyun, Lee, Syng-ook, Brents, Lisa K., Prather, Paul L., Safe, Stephen
Pubblicato in Mol Cancer Ther (2012)

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial ag...

di Brents, Lisa K., Gallus-Zawada, Anna, Radominska-Pandya, Anna, Vasiljevik, Tamara, Prisinzano, Thomas E., Fantegrossi, William E., Moran, Jeffery H., Prather, Paul L.
Pubblicazione 2012

Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors

di Brents, Lisa K., Medina-Bolivar, Fabricio, Seely, Kathryn A., Nair, Vipin, Bratton, Stacie M., Ñopo-Olazabal, Luis, Patel, Ronak Y., Liu, Haining, Doerksen, Robert J., Prather, Paul L., Radominska-Pandya, Anna
Pubblicazione 2011

Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

di Chimalakonda, Krishna C., Seely, Kathryn A., Bratton, Stacie M., Brents, Lisa K., Moran, Cindy L., Endres, Gregory W., James, Laura P., Hollenberg, Paul F., Prather, Paul L., Radominska-Pandya, Anna, Moran, Jeffery H.
Pubblicazione 2012

In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome

di Griffin, Bryce A., Caperton, Caitlin O., Russell, Lauren N., Cabanlong, Christian V., Wilson, Catheryn D., Urquhart, Kyle R., Martins, Bradford S., Zita, Marcelle Dina, Patton, Amy L., Alund, Alexander W., Owens, S. Michael, Fantegrossi, William E., Moran, Jeffery H., Brents, Lisa K.
Pubblicato in J Pharmacol Exp Ther (2019)